Gene set name | Description | Genes in overlap (number, genes) | p-value | FDR q-value |
---|---|---|---|---|
BIOCARTA CTLA-4 pathway | The co-stimulatory signal during T cell activation | 7: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, CD3E, ICOS, CTLA-4 | 6e−14 | 1.72e−10 |
KEGG hematopoietic cell lineage | Hematopoietic cell lineage | 9: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, CD3E, CD2, ITGA6, IL2RA, CD59 | 7.78e−13 | 1.12e−9 |
REACTOME costimulation by the CD28 FAM family | Costimulation by the CD28 family | 8: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, CD3E, ICOS, CTLA-4, HLA-DQB1 | 1.07e−11 | 1.02e−8 |
KEGG cell adhesion molecules (CAMs) | Cell adhesion molecules (CAMs) | 9: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, ICOS, CTLA-4, CD2, ITGA6, HLA-DQB1 | 3.77e−11 | 2.71e−8 |
REACTOME PD-1 signaling | PD-1 signaling | 6: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, CD3E, HLA-DQB1 | 5.82e−11 | 3.34e−8 |
BIOCARTA TCRA pathway | Lck and Fyn tyrosine kinases in initiation of TCR activation | 5: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, CD3E | 1.4e−10 | 6.68e−8 |
REACTOME generation of second messenger molecules | Generation of second messenger molecules | 6: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, CD3E, HLA-DQB1 | 4.94e−10 | 2.02e−7 |
KEGG graft-versus-host disease | Graft-versus-host disease | 6: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, KLRD1, HLA-DQB1 | 6.78e−10 | 2.43e−7 |
BIOCARTA Csk pathway | Activation of Csk by cAMP-dependent protein kinase inhibits signaling through the T cell receptor | 5: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, CD3E | 1.81e−9 | 5.24e−7 |
KEGG intestinal immune network for IgA production | Intestinal immune network for IgA production | 6: HLA-DRB1, HLA-DRB5, HLA-DRB3, HLA-DRB4, ICOS, HLA-DQB1 | 1.83e−9 | 5.24e−7 |